Adolescent Female Assent in Clinical Trials: A Model Assent Process
Multiple issues concerning the assent process for adolescent female participation in clinical trials are present in a process that has historically been based on an adult developmental and cognitive perspective. Adolescents are experiencing physiological and psycho-social, sexual growth and, therefore, should not be approached as though they are adults. This paper addresses important assent elements from the unique developmental perspective of female adolescents including sexual activity, birth control, privacy rights, confidentiality, and pregnancy. A proposed assent process and model assent form addressing these important issues are presented.
Key WordsFemale adolescents Clinical trials Assent
Unable to display preview. Download preview PDF.
- 1.National Institutes of Health. Policy and Guidelines on the Inclusion of children as Participants in Research Involving Human Subjects. Bethesda, MD: National Institutes of Health; 1998.Google Scholar
- 2.Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients. Rockville, MD: Food and Drug Administration; 1997.Google Scholar
- 3.Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients: Final Rule. Federal Register. 1998;63(December 2):66631–66672.Google Scholar
- 6.Nicholson RH. Medical Research with Children: Ethics, Law and Practice. Oxford: Oxford University Press, 1986.Google Scholar
- 10.Alan Guttmacher Institute. Sex and America’s Teenagers. New York: Alan Guttmacher Institute; 1994.Google Scholar
- 12.Trussell J, Card JJ, Hogue CJ. Adolescent Sexual Behavior, Pregnancy and Childbearing. In Hatcher RA, Trussell J, Stewart F, Cates W, Setward GK, Guest F, Kowal D. Contraceptive Technology. 17th ed. New York: Ardent Media, Inc.; 1998.Google Scholar
- 14.Gilligan C. In a Different Voice: Psychological Theory and Women’s Development. Cambridge, MA: Harvard University Press; 1993.Google Scholar
- 16.Food and Drug Administration. FDA Information Sheets. Evaluation of Gender Differences in Clinical Investigations. Rockville, MD: Food and Drug Administration; 1995;71.Google Scholar
- 21.Humphey GB, Boon CM, van Linden van den Heuvell GF, van de wiel HB. The occurrence of high levels of acute behavioral distress in children and adolescents undergoing routine venipunctures. Pediatrics. 1992;90(1):87–91.Google Scholar
- 22.Fassler D. The aetiology and treatment of needle phobia in the young patient—A review. Am J Ortho-psychiatry. 1985;55(3):371–377.Google Scholar